Clinical Trials Browser

Recruiting × Blood Specimen Collection × Clear all

NCT05710679 2026-05-26

NeckTAR

Phase NA Recruiting

Locally Advanced Head and Neck Carcinoma

NCT06492122 2026-05-26

ProTACT

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT03387865 2026-05-22

Bio-lung

Lung Neoplasms, Neoplasms

NCT06430021 2026-05-22

PRO-NEM1

Neuroendocrine Tumors

NCT06480591 2026-05-22

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Myeloproliferative Disorders, Thrombosis

NCT06086704 2026-05-18

Study of 18F-FFNP Breast PET/MRI

Phase 2 Recruiting

Breast Neoplasms

NCT03869814 2026-05-15

Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

20,000 enrolled

Diagnosis of Cancer of Various Organs

NCT04261192 2026-05-12

ORGAVADS

Head and Neck Neoplasms

NCT02743858 2026-05-07

Lymphedema Surveillance Study

Breast Neoplasms, Lymphedema

NCT03874559 2026-05-06

Exosomes in Rectal Cancer

Gastrointestinal

Rectal Neoplasms

NCT05119244 2026-05-06

ECP

Phase NA Recruiting

Marijuana Abuse, Lung Neoplasms

NCT05354765 2026-05-06

ALCYTA

Phase NA Recruiting

Neoplasms

NCT06274515 2026-05-06

REMERGE

Phase 4 Recruiting

Breast Neoplasms

NCT06127979 2026-05-05

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Phase NA Recruiting

Breast Neoplasms

NCT06682442 2026-05-01

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Phase NA Recruiting

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT07560865 2026-05-01

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

Phase 1 Recruiting

Astrocytoma, Glioblastoma, Disease Progression

NCT02530658 2026-04-29

Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Central Nervous System Neoplasms, Genetic Predisposition to Disease

NCT05306912 2026-04-29

KOBE

Phase NA Recruiting

Lung Neoplasms

NCT06247826 2026-04-29

RESAMEX

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06620835 2026-04-29

OPTALK

Phase 2 Recruiting

Lung Neoplasms

NCT00898313 2026-04-27

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

Lung Neoplasms

NCT06147414 2026-04-23

DANNIgene

CNSClassical hematologyGenitourinary

Hydrocephalus, X-linked, Neurofibromatosis-Noonan syndrome, Anemia, Sickle Cell, Hemophilia B, Cystic Fibrosis, Fragile X Syndrome, Hemophilia A, Huntington Disease, Myotonic Dystrophy, Polycystic Kidney, Autosomal Recessive, Neurofibromatoses, Muscular Dystrophy, Duchenne

NCT06861244 2026-04-23

PNOC031

Phase 2 Recruiting

Neuroectodermal Tumors, Primitive, Pyloric Stenosis, Hypertrophic

NCT06705335 2026-04-20

CONVERCAP

Gastrointestinal

Pancreatic Neoplasms

NCT05051722 2026-04-17

ECHO

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Endometrial Hyperplasia, Ovarian Neoplasms, Endometrial Neoplasms

NCT06666803 2026-04-16

Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)

Phase NA Recruiting

Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma

NCT00260585 2026-04-14

Esophageal Cancer Risk Registry

Gastrointestinal

Esophageal Achalasia, Esophageal Diseases, Esophageal Neoplasms, Gastroesophageal Reflux, Hernia, Hiatal

NCT05088395 2026-04-14

ALCINA4

Phase NA Recruiting

Neoplasms

NCT04406831 2026-04-13

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT05030038 2026-04-13

Oral Aromatase Inhibitors Modify the Gut Microbiome

Breast Neoplasms

NCT02087852 2026-04-09

Kidney Cancer DNA Registry

Kidney Neoplasms

NCT07284589 2026-04-08

Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake

Phase 2 Recruiting

Neoplasms

NCT04300998 2026-04-07

Study of CAR-T Therapy in Older Patients

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Lymphoma, B-Cell

NCT06618703 2026-04-06

BIChE-1

Phase NA Recruiting

Brain Neoplasms, Radiation Injuries

NCT06962995 2026-04-06

Multi-Cancer Detection Observational Cohort Study

Neoplasms

NCT04141462 2026-04-03

EX²TRICAN

Phase NA Recruiting

Neoplasms, Genetic Predisposition to Disease

NCT07054346 2026-04-01

LUTACT

Phase 1 Recruiting

Disease, Prostatic Neoplasms

NCT05981326 2026-03-31

NEOEPICURE

Phase NA Recruiting

Breast Neoplasms

NCT06875609 2026-03-30

ctDNA in Cutaneous Squamous Cell Carcinoma

Skin Neoplasms, Neoplasm, Residual

NCT04167969 2026-03-27

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms

NCT04615988 2026-03-27

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

Neoplasms, Thyroid Diseases, Vitamin D Deficiency

NCT05754892 2026-03-27

COMETE-CARE

Phase NA Recruiting

Neoplasms

NCT07276360 2026-03-27

HypoRTCx-UG

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT05847855 2026-03-25

Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors

Adenoma, Islet Cell

NCT05212272 2026-03-23

MRI in High-Grade Glioma Patients Undergoing Chemoradiation

Phase NA Recruiting

Glioma

NCT03010124 2026-03-20

OvBIOMark

Phase NA Recruiting

Ovarian Neoplasms

NCT05191940 2026-03-20

LAPC

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05595577 2026-03-20

PALS

Phase NA Recruiting

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT05692635 2026-03-20

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Phase 2 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05435495 2026-03-18

Mechanisms of Resistance to PSMA Radioligand Therapy

Prostatic Neoplasms